Dr. Siavash Md Jabbari, MD

Dr. Jabbari practices at Sharp Memorial Hospital in San Diego, California, part of Sharp HealthCare.

Dr. Jabbari's NPI, 1720314107, was assigned on October 20, 2009. Dr. Jabbari graduated from University Of Michigan Medical School in 2005. Dr. Jabbari holds California license A99269.

Dr. Jabbari's primary practice is Sharp Memorial Hospital, at 7901 Frost St, San Diego, CA 92123 in San Diego County. The practice phone is (858) 939-3400.

Dr. Jabbari's primary practice is Sharp Memorial Hospital in San Diego, California, part of Sharp HealthCare. Dr. Jabbari is also affiliated with Sharp Chula Vista Medical Center. The medical group on file is X-Ray Medical Group, Inc. Dmand AI also links Dr. Jabbari to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jabbari practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Jabbari's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Jabbari is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Jabbari's licenses on file in 2 states: California and Illinois.

Dmand AI lists bone cancer radiation, brain cancer radiation, breast cancer radiation, cancer radiation-upper GI, cervical cancer radiation, head & neck cancer radiation, lung cancer radiation and prostate cancer radiation among the conditions Dr. Jabbari treats.

CMS data shows 1,267 Medicare services from Dr. Jabbari across 16 procedure codes in 2024, for 131 Medicare patients. Medicare paid $100,655 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 131 Medicare patients who saw Dr. Jabbari in 2024. The largest group is 65 to 74, with 56 patients. 74% of them have high blood pressure, and 66% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jabbari's median patient age at 69, with 38% women.

In 2024, Dr. Jabbari wrote 98 Medicare Part D claims for 33 patients. 98% of them were for generic drugs. CMS names the drug for 35 of them, across 2 drugs with 11 or more claims each, at $430 in total drug cost. In 2022, CMS named 12 claims across 1 drug.

Dr. Jabbari accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 18 papers to Dr. Jabbari, published from 2005 to 2011. 2005 was the busiest year, with 2. The most frequent topics are Radiosurgery, Head and Neck Neoplasms and Radiotherapy Dosage. Dr. Jabbari has published most often in Int J Radiat Oncol Biol Phys. Dr. Jabbari's most frequent co-authors are Johnny R. Bernard, MD, Carol R. Bradford, MD and Douglas B. Chepeha, MD.

Dmand AI links Dr. Jabbari to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Brain Neoplasms, Glioblastoma and Prostatic Neoplasms.

CMS Open Payments shows 72 general payments to Dr. Jabbari from 10 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 66% of the total. Medtronic Vascular, Inc. paid the most, $21,270.

Dr. Jabbari graduated from University Of Michigan Medical School in 2005.

Dr. Jabbari is in network with 10 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.